1100 related articles for article (PubMed ID: 7691885)
21. The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis.
Besmer P; Manova K; Duttlinger R; Huang EJ; Packer A; Gyssler C; Bachvarova RF
Dev Suppl; 1993; ():125-37. PubMed ID: 7519481
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic activation of v-kit involves deletion of a putative tyrosine-substrate interaction site.
Herbst R; Munemitsu S; Ullrich A
Oncogene; 1995 Jan; 10(2):369-79. PubMed ID: 7530827
[TBL] [Abstract][Full Text] [Related]
23. MEG-01s cells have receptors for and respond to IL-3, IL-6, and SCF.
Kellar KL; Hooper WC; Benson JM
Exp Hematol; 1995 Jun; 23(6):557-64. PubMed ID: 7539384
[TBL] [Abstract][Full Text] [Related]
24. The c-kit proto-oncogene receptor is expressed on a subset of human CD3-CD4-CD8- (triple-negative) thymocytes.
deCastro CM; Denning SM; Langdon S; Vandenbark GR; Kurtzberg J; Scearce R; Haynes BF; Kaufman RE
Exp Hematol; 1994 Sep; 22(10):1025-33. PubMed ID: 7522182
[TBL] [Abstract][Full Text] [Related]
25. Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell line.
Hashimoto K; Tsujimura T; Moriyama Y; Yamatodani A; Kimura M; Tohya K; Morimoto M; Kitayama H; Kanakura Y; Kitamura Y
Am J Pathol; 1996 Jan; 148(1):189-200. PubMed ID: 8546206
[TBL] [Abstract][Full Text] [Related]
26. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
[TBL] [Abstract][Full Text] [Related]
27. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
Shivakrupa R; Bernstein A; Watring N; Linnekin D
Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
[TBL] [Abstract][Full Text] [Related]
28. Induction of the murine "W phenotype" in long-term cultures of human cord blood cells by c-kit antisense oligomers.
Migliaccio AR; Migliaccio G; Mancini G; Ratajczak M; Gewirtz AM; Adamson JW
J Cell Physiol; 1993 Oct; 157(1):158-63. PubMed ID: 7691834
[TBL] [Abstract][Full Text] [Related]
29. Cell type-specific deficiency of c-kit gene expression in mutant mice of mi/mi genotype.
Isozaki K; Tsujimura T; Nomura S; Morii E; Koshimizu U; Nishimune Y; Kitamura Y
Am J Pathol; 1994 Oct; 145(4):827-36. PubMed ID: 7524330
[TBL] [Abstract][Full Text] [Related]
30. Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1.
Ashman LK; Bühring HJ; Aylett GW; Broudy VC; Müller C
J Cell Physiol; 1994 Mar; 158(3):545-54. PubMed ID: 7510297
[TBL] [Abstract][Full Text] [Related]
31. Role for the stem cell factor/KIT complex in Schwann cell neoplasia and mast cell proliferation associated with neurofibromatosis.
Ryan JJ; Klein KA; Neuberger TJ; Leftwich JA; Westin EH; Kauma S; Fletcher JA; DeVries GH; Huff TF
J Neurosci Res; 1994 Feb; 37(3):415-32. PubMed ID: 7513766
[TBL] [Abstract][Full Text] [Related]
32. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
Beghini A; Cairoli R; Morra E; Larizza L
Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
[TBL] [Abstract][Full Text] [Related]
33. Expression of the c-kit mRNA in human aortic endothelial cells.
Miyamoto T; Sasaguri Y; Sugama K; Azakami S; Morimatsu M
Biochem Mol Biol Int; 1994 Oct; 34(3):513-20. PubMed ID: 7530545
[TBL] [Abstract][Full Text] [Related]
34. Primary acute myeloid leukemia cells negative for c-kit receptor protein expression do not proliferate in vitro in response to colony-stimulating factors.
Hirakawa K; Kimura S; Chikayama S; Misawa S; Maekawa T
Leukemia; 1996 Feb; 10(2):279-87. PubMed ID: 8637237
[TBL] [Abstract][Full Text] [Related]
35. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product.
Asano Y; Brach MA; Ahlers A; de Vos S; Butterfield JH; Ashman LK; Valent P; Gruss HJ; Herrmann F
J Immunol; 1993 Sep; 151(5):2345-54. PubMed ID: 7689605
[TBL] [Abstract][Full Text] [Related]
36. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
[TBL] [Abstract][Full Text] [Related]
37. An increase in the expression and total activity of endogenous p60(c-Src) in several factor-independent mutants of a human GM-CSF-dependent leukemia cell line (TF-1).
Horn S; Meyer J; Stocking C; Ostertag W; Jücker M
Oncogene; 2003 Oct; 22(46):7170-80. PubMed ID: 14562045
[TBL] [Abstract][Full Text] [Related]
38. The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.
Pedersen M; Rönnstrand L; Sun J
Cell Signal; 2009 Mar; 21(3):413-8. PubMed ID: 19049823
[TBL] [Abstract][Full Text] [Related]
39. Steel factor-induced tyrosine phosphorylation in murine mast cells. Common elements with IL-3-induced signal transduction pathways.
Welham MJ; Schrader JW
J Immunol; 1992 Oct; 149(8):2772-83. PubMed ID: 1383327
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation.
Mekori YA; Metcalfe DD
J Immunol; 1994 Sep; 153(5):2194-203. PubMed ID: 7519644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]